IBIOvs its industry peers
A metric-by-metric comparison of IBIO against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IBIOEsta | — | — | — | — | — | — | — | — | — | — | — | — |
| MNOV | $65M#3 | — | 1.7x#2 | 159.8x#2 | — | 8.6%#2 | -3242.5%#2 | 30.4%#2 | — | — | — | — |
| PLRX | $65M#4 | — | 0.4x#1 | — | — | -29.0%#4 | — | 90.4%#1 | — | — | — | — |
| EVFM | $63M#5 | — | — | 3.1x#1 | 4.2%#1 | 104.4%#1 | 16.7%#1 | — | — | — | — | — |
| OSTX | $68M#2 | — | — | — | — | -223.7%#5 | — | — | — | — | -13.8%#1 | — |
| SILO | $69M#1 | — | 12.2x#3 | 960.0x#3 | 0.0%#2 | 3.8%#3 | -5937.0%#3 | -74.4%#3 | — | — | -63.9%#2 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-08-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice